Immunocore
↗Abingdon, United Kingdom
Immunocore is a commercial-stage biotechnology company that pioneered the development of a novel class of T-cell receptor (TCR) bispecific immunotherapies called ImmTAC (Immune mobilizing monoclonal TCRs Against Cancer). These molecules are designed to target intracellular antigens, a capability that distinguishes them from traditional antibody-based therapies which are limited to cell-surface targets.
The company's lead product, KIMMTRAK, is the first-ever TCR therapeutic to receive regulatory approval and is currently the standard of care for HLA-A*02:01-positive patients with metastatic uveal melanoma. Immunocore is leveraging its proprietary ImmTAX platform to expand into other therapeutic areas, including infectious diseases (HIV, HBV) and autoimmune conditions (Type 1 Diabetes).
CLASSIFICATION
SIZE & FINANCIALS
Employees:501-1000
Revenue:$400M
Founded:2008
Ownership:public
Status:operating
FUNDING
Stage:Post-IPO
Total Raised:$601M
Investors:General Atlantic, BlackRock, Fidelity Management & Research Company, RTW Investments, Deep Track Capital
STOCK
Exchange:NASDAQ
Ticker:IMCR
Market Cap:$1.63B
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial (KIMMTRAK)
Modalities:TCR bispecifics, ImmTAC, ImmTAV, ImmTAAI
Active Trials:12
Trial Phases:Phase 1: 5 | Phase 2: 4 | Phase 3: 3
FDA Approvals:1
EMA Approvals:1
CORPORATE STRUCTURE
Subsidiaries:Immunocore Limited, Immunocore LLC
Key Partnerships:GSK (TCR discovery), AstraZeneca (Combination studies), Eli Lilly (ImmTAC collaboration), Genentech (MAGE-A4 target)
COMPETITION
Position:Leader
Competitors:Immatics, Adaptimmune, TScan Therapeutics, Amgen, Kite Pharma
LEADERSHIP
Key Executives:
Bahija Jallal - CEO
Mohammed Dar - EVP, Clinical Development
Scientific Founders:Bent Jakobsen
Board Members:Bahija Jallal, Travis Coy, Sir John Bell
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Immunocore. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.